Home
Scholarly Works
Recommending defunct therapies is a safety risk...
Journal article

Recommending defunct therapies is a safety risk for hemophilia

Authors

Pierce GF; O'Mahony B; Kaczmarek R; Mekhuzla S; Skinner MW

Journal

Blood Transfusion, Vol. 23, No. 2, pp. 189–190

Publication Date

March 1, 2025

DOI

10.2450/bloodtransfus.982

ISSN

1723-2007
View published work (Non-McMaster Users)

Contact the Experts team